Sufentanil Citrate Injection shortage
Current 4 presentations · 2 manufacturers · first FDA posting May 3, 2022 · last update Oct 14, 2026
Manufacturers: Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company
Stated reasons (per FDA): Other
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Not currently manufactured | Posted May 3, 2022 Updated Oct 14, 2026 |
| Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Not currently manufactured | Posted May 3, 2022 Updated Oct 14, 2026 |
| Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05) | Hikma Pharmaceuticals USA, Inc. | Current Unavailable |
Other | Not currently manufactured | Posted May 3, 2022 Updated Oct 14, 2026 |
| Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted May 3, 2022 Updated Oct 8, 2026 |